TELA Bio, Inc. TELA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -4.49% | 2.91% | 18.24% | 9.14% | 25.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.49% | 2.91% | 18.24% | 9.14% | 25.52% |
| Cost of Revenue | -12.41% | 8.98% | 10.83% | 10.34% | 21.82% |
| Gross Profit | -1.14% | 0.06% | 22.39% | 8.58% | 27.15% |
| SG&A Expenses | -2.29% | 1.27% | 4.15% | -4.86% | 3.26% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.40% | 2.05% | 5.82% | -0.28% | 5.85% |
| Operating Income | -2.22% | -0.52% | 20.42% | 19.34% | 21.51% |
| Income Before Tax | -13.27% | -8.93% | 4.88% | 17.06% | 21.51% |
| Income Tax Expenses | 81.82% | 15.38% | 200.69% | -- | -- |
| Earnings from Continuing Operations | -13.49% | -8.96% | 1.81% | 17.06% | 21.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.49% | -8.96% | 1.81% | 17.06% | 21.25% |
| EBIT | -2.22% | -0.52% | 20.42% | 19.34% | 21.51% |
| EBITDA | -2.34% | -0.56% | 20.59% | 19.73% | 22.17% |
| EPS Basic | 10.29% | 13.83% | 23.89% | 54.89% | 57.19% |
| Normalized Basic EPS | 10.56% | 13.89% | 33.65% | 54.88% | 57.31% |
| EPS Diluted | 10.29% | 13.83% | 23.89% | 54.89% | 57.19% |
| Normalized Diluted EPS | 10.56% | 13.89% | 33.65% | 54.88% | 57.31% |
| Average Basic Shares Outstanding | 26.56% | 26.49% | 28.97% | 83.87% | 83.94% |
| Average Diluted Shares Outstanding | 26.56% | 26.49% | 28.97% | 83.87% | 83.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |